 We're going to first take a break, and we're talking about post-transplant drugs, what's holding up potential new medications. We're joined by Dr. Ken Newell. He's a transplant surgeon at Emory University Hospital. He was also the president of the American Society of Transplantation. Also with us is Bill Fitzsimmons, an advisor to the Transplant Therapeutic Consortium. I'm Debra Becker. This is On Point.